Influenza vaccine: Issues and opportunities

Infectious Disease Clinics of North America

Volumn 15, Issue 1, 2001, Pages 123-141

  Neuzil, Kathleen M ^a   Griffin, Marie R ^b,c,e   Schaffner, William ^b,d,e  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Department of Preventive Medicine ^*  (United States)

^c Division of General Internal Medicine

^d Division of Infectious Diseases   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; INFLUENZA VACCINE; OSELTAMIVIR; RIMANTADINE; ZANAMIVIR;

ADULT; AGED; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED DISEASE; HIGH RISK POPULATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MORBIDITY; MORTALITY; REVIEW; RISK BENEFIT ANALYSIS; VIRUS TRANSMISSION;

EID: 0035062971     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70271-3     Document Type: Article

References (84)

1. Impact of epidemic type A influenza in a defined adult population
2. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
3. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children
4. Pneumonia and Hong Kong influenza: A prospective study of the 1968-1969 epidemic
5. Effects of influenza vaccination of healthcare workers on mortality of elderly people in long-term care: A randomised controlled trial
6. Increase in pneumonia mortality among young adults and the HIV epidemic - New York City, United States
7. Influenza and pneumococcal vaccination levels among adults aged >65 years - United States, 1997
8. Prevention and control of influenza
9. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
10. Recommendations regarding the use of vaccines that contain thimerosal as a preservative
11. Serologic response to standard inactivated influenza vaccine in human immunodeficiency virus-infected children
12. Resistance of adults to challenge with influenza A wild-type virus after receiving live or inactivated virus vaccine
13. Susceptibility to influenza A in HIV-positive patients
14. Editorial response: Influenza, influenza virus vaccine, and human immunodeficiency virus infection
15. Influenza: Its control in persons and populations
16. Influenza
17. A/NJ/8/76 influenza vaccination program: Effects on maternal health and pregnancy outcome
18. Vaccines for preventing influenza in healthy adults
19. Epidemiologic studies of Asian influenza in a Louisiana parish
20. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of Influenza A disease
21. An influenza simulation model for immunization studies
22. Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants
23. Prolonged influenza A infection responsive to rimantadine therapy in a human immunodeficiency virus-infected child
24. Cigarette smoking and epidemic influenza
25. Deaths from Asian influenza associated with pregnancy
26. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: Impact on plasma levels of HIV Type 1 RNA and determinants of antibody response
27. The effect of influenza vaccination on human immunodeficiency virus type 1 load: A randomized, double-blind, placebo-led study
28. Maternal mortality in the epidemic of Asian influenza, New York City, 1957
29. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy
30. Influenza: A shot or not?
31. Influenza vaccination in HIV-infected children: Serologic response, viral load changes and effect of vitamin A supplementation
32. Influenza occurring in pregnant women
33. Response to influenza immunisation in asymptomatic HIV infected men
34. Influenza and the rates of hospitalization for respiratory disease among infants and young children
35. Influenza pneumonia at term
36. Immunity to influenza A virus infection in young children: A comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine
37. Smoking and epidemic influenza-like illness in female military recruits: A brief survey
38. Cigarette smoking as a risk factor for epidemic A (H1N1) influenza in young men
39. Influenza A and B virus infection in infants and young children during the years 1957-1976
40. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent types A and B, live, cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults
41. Fatal influenza A pneumonia in pregnancy
42. Antibody response to influenza, tetanus and pneumococal vaccines in HIV-seropositive individuals in relation to the number of CD4 lymphocytes
43. The Guillain-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines
44. Asian influenza A in Boston, 1957-1958
45. Influenza B virus encephalitis
46. Is it time to give influenza vaccine to healthy infants?
47. Fatal swine influenza pneumonia during late pregnancy
48. Viral respiratory disease at Lowry Air Force Base in Denver, 1952-1982
49. The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine
50. Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of school children
51. Impact of type A influenza on children: A retrospective study
52. Risk of acute respiratory disease among pregnant women during influenza A epidemics
53. Influenza: New insights into an old disease
54. The impact of influenza on hospitalizations, outpatient visits, and antibiotic prescriptions in children
55. Influenza-associated morbidity and mortality in young and middle-aged women
56. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women
57. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community
58. Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults
59. Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma
60. Effect of rapid diagnosis on management of Influenza A infections
61. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients
62. Protection of infants from infection with Influenza A by transplacentally acquired antibody
63. Severe influenza pneumonia in HIV patients during 1997-1998 influenza season
64. Fatal influenzal pneumonia in pregnancy: Failure to demonstrate transmission of influenza virus
65. Pneumonia complicating pregnancy
66. Influenza in patients with human immunodeficiency virus infection
67. Clinical, virologic and immunologic features of influenza vaccination in HIV infection
68. Respiratory infection in pregnancy
69. Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults
70. As good as the real thing
71. Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: Reactogenicity and immunogenicity in mother and infant
72. Effects of influenza vaccination in HIV-infected adults: A double-blind, placebo-controlled trial
73. Efficacy of influenza vaccination in HIV-infected persons. A randomized, double-blind, placebo-controlled trial
74. Influenza A pneumonitis in a patient infected with a human immunodeficiency virus (HIV)
75. Herd immunity following subunit influenza vaccine administration
76. Epidemic pneumonia (Spanish influenza) in pregnancy
77. Influenza A infections in young children, Primary natural infection and protective efficacy of live-vaccine-induced or naturally acquired immunity
78. Differing virulence of H1N1 and H3N2 influenza strains
79. Transplacental transfer of influenza virus
80. Influenza immunization of HIV-1-infected patients does not increase HIV-1 viral load
81. Lowering the age for routine influenza vaccination to 50 years: AAFP leads the nation in influenza vaccine policy